New York State Common Retirement Fund
IRWD icon

New York State Common Retirement Fund’s Ironwood Pharmaceuticals IRWD Stock Holding History

New York State Common Retirement Fund’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Hold
41,869
– – ﹤0.01% 2352
2025
Q4 		$141K Hold
41,869
– – ﹤0.01% 2448
2025
Q3 		$54.8K Hold
41,869
– – ﹤0.01% 2923
2025
Q2 		$30K Hold
41,869
– – ﹤0.01% 3064
2025
Q1 		$61.5K Hold
41,869
– – ﹤0.01% 2703
2024
Q4 		$185K Hold
41,869
– – ﹤0.01% 2329
2024
Q3 		$173K Sell
41,869
-749,836
-95% -$4.03M ﹤0.01% 2369
2024
Q2 		$5.16M Sell
791,705
-17,297
-2% -$122K 0.01% 1111
2024
Q1 		$7.05M Buy
809,002
+17,266
+2% +$210K 0.01% 968
2023
Q4 		$9.06M Buy
791,736
+8,740
+1% +$86.5K 0.01% 876
2023
Q3 		$7.54M Sell
782,996
-24,570
-3% -$241K 0.01% 944
2023
Q2 		$8.59M Sell
807,566
-26,382
-3% -$284K 0.01% 956
2023
Q1 		$8.77M Sell
833,948
-28,131
-3% -$315K 0.01% 941
2022
Q4 		$10.7M Sell
862,079
-426,977
-33% -$4.84M 0.01% 840
2022
Q3 		$13.4M Sell
1,289,056
-341,588
-21% -$3.87M 0.02% 710
2022
Q2 		$18.8M Sell
1,630,644
-190,812
-10% -$2.25M 0.02% 572
2022
Q1 		$22.9M Buy
1,821,456
+9,150
+0.5% +$105K 0.02% 568
2021
Q4 		$21.1M Buy
1,812,306
+46,036
+3% +$565K 0.02% 635
2021
Q3 		$23.1M Sell
1,766,270
-592,507
-25% -$7.66M 0.02% 605
2021
Q2 		$30.4M Sell
2,358,777
-11,105
-0.5% -$127K 0.03% 502
2021
Q1 		$26.5M Sell
2,369,882
-9,000
-0.4% -$95.1K 0.03% 544
2020
Q4 		$27.1M Sell
2,378,882
-900
-0% -$9.85K 0.03% 522
2020
Q3 		$21.4M Hold
2,379,782
– – 0.03% 561
2020
Q2 		$24.6M Buy
2,379,782
+336,441
+16% +$3.44M 0.03% 506
2020
Q1 		$20.6M Hold
2,043,341
– – 0.03% 514
2019
Q4 		$27.2M Sell
2,043,341
-20,600
-1% -$227K 0.03% 519
2019
Q3 		$17.7M Buy
2,063,941
+5,213
+0.3% +$50.7K 0.02% 684
2019
Q2 		$22.5M Buy
2,058,728
+435,966
+27% +$4.88M 0.03% 599
2019
Q1 		$18.4M Sell
1,622,762
-23,371
-1% -$261K 0.02% 684
2018
Q4 		$14.3M Sell
1,646,133
-130,754
-7% -$1.5M 0.02% 733
2018
Q3 		$27.5M Buy
1,776,887
+39,496
+2% +$624K 0.03% 546
2018
Q2 		$27.8M Buy
1,737,391
+54,499
+3% +$807K 0.03% 527
2018
Q1 		$21.7M Hold
1,682,892
– – 0.03% 632
2017
Q4 		$21.1M Buy
1,682,892
+5,729
+0.3% +$74.8K 0.03% 663
2017
Q3 		$22.2M Buy
1,677,163
+56,924
+4% +$783K 0.03% 596
2017
Q2 		$25.6M Buy
1,620,239
+441,816
+37% +$6.42M 0.03% 523
2017
Q1 		$16.8M Buy
1,178,423
+1,014,726
+620% +$13.9M 0.02% 716
2016
Q4 		$2.1M Hold
163,697
– – ﹤0.01% 1663
2016
Q3 		$2.18M Buy
163,697
+15,044
+10% +$176K ﹤0.01% 1601
2016
Q2 		$1.63M Hold
148,653
– – ﹤0.01% 1711
2016
Q1 		$1.36M Buy
148,653
+5,731
+4% +$47.3K ﹤0.01% 1787
2015
Q4 		$1.39M Hold
142,922
– – ﹤0.01% 1794
2015
Q3 		$1.25M Sell
142,922
-9,826
-6% -$91.7K ﹤0.01% 1828
2015
Q2 		$1.54M Buy
+152,748
New +$1.78M ﹤0.01% 1974

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

New York State Common Retirement Fund's IRWD Position: Q1 2026 in Review

New York State Common Retirement Fund held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 41,869 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

New York State Common Retirement Fund first reported a position in IRWD in Q2 2015 and has held it in 44 quarters since. The position peaked at $30.4M in Q2 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • New York State Common Retirement Fund held 41,869 shares of Ironwood Pharmaceuticals worth $147K as of Q1 2026.
  • New York State Common Retirement Fund left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2352 holding.
  • New York State Common Retirement Fund first reported a position in Ironwood Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • New York State Common Retirement Fund's Ironwood Pharmaceuticals position peaked at $30.4M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.